SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-036875
Filing Date
2023-11-06
Accepted
2023-11-06 07:08:36
Documents
77
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrtx-20230930.htm   iXBRL 10-Q 1440014
2 EX-10.1 mrtx-2023930xex101.htm EX-10.1 104978
3 EX-10.2 mrtx-2023930xex102.htm EX-10.2 90161
4 EX-10.3 mrtx-2023930xex103.htm EX-10.3 14989
5 EX-10.4 mrtx-2023930xex104.htm EX-10.4 14515
6 EX-10.5 mrtx-2023930xex105.htm EX-10.5 69154
7 EX-10.6 mrtx-2023930xex106.htm EX-10.6 55415
8 EX-10.7 mrtx-2023930xex107.htm EX-10.7 6385
9 EX-31.1 mrtx-2023930xex311.htm EX-31.1 12223
10 EX-31.2 mrtx-2023930xex312.htm EX-31.2 13314
11 EX-32.1 mrtx-2023930xex321.htm EX-32.1 7739
17 image_0.jpg GRAPHIC 32424
  Complete submission text file 0001628280-23-036875.txt   7063053

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrtx-20230930.xsd EX-101.SCH 43954
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrtx-20230930_cal.xml EX-101.CAL 68865
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrtx-20230930_def.xml EX-101.DEF 191466
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrtx-20230930_lab.xml EX-101.LAB 603552
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrtx-20230930_pre.xml EX-101.PRE 374941
71 EXTRACTED XBRL INSTANCE DOCUMENT mrtx-20230930_htm.xml XML 844820
Mailing Address 3545 CRAY COURT SAN DIEGO CA 92121
Business Address 3545 CRAY COURT SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35921 | Film No.: 231378089
SIC: 2834 Pharmaceutical Preparations